List of Genmab A/S patents

Patents where

Current Assignee

Name

‌

Genmab A/S

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10906991 Bispecific antibodies and methods for production thereof	Patent 10906991 was granted and assigned to Genmab A/S on February, 2021 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	10906991	February 2, 2021
‌ US Patent 11578141 Bispecific antibodies against HER2 and CD3		‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11578141	February 14, 2023
‌ US Patent 7507408 Anti hepatitis C virus antibody and uses thereof	Patent 7507408 was granted and assigned to Genmab A/S on March, 2009 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7507408	March 24, 2009
‌ US Patent 7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)	Patent 7247301 was granted and assigned to Genmab A/S on July, 2007 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7247301	July 24, 2007
‌ US Patent 7595378 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)	Patent 7595378 was granted and assigned to Genmab A/S on September, 2009 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7595378	September 29, 2009
‌ US Patent 9212230 Bispecific antibodies and methods for production thereof	Patent 9212230 was granted and assigned to Genmab A/S on December, 2015 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	9212230	December 15, 2015
‌ US Patent 10344050 Production of heterodimeric proteins	Patent 10344050 was granted and assigned to Genmab A/S on July, 2019 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	10344050	July 9, 2019
‌ US Patent 8182812 Human monoclonal antibodies against CD25	Patent 8182812 was granted and assigned to Genmab A/S on May, 2012 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	8182812	May 22, 2012
‌ US Patent 7829673 Antibodies against CD38 for treatment of multiple myeloma	Patent 7829673 was granted and assigned to Genmab A/S on November, 2010 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7829673	November 9, 2010
‌ US Patent 7153507 Human antibodies specific for interleukin 15 (IL-15)	Patent 7153507 was granted and assigned to Genmab A/S on December, 2006 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7153507	December 26, 2006
‌ US Patent 7438907 Human monoclonal antibodies against CD25	Patent 7438907 was granted and assigned to Genmab A/S on October, 2008 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7438907	October 21, 2008
‌ US Patent 11492371 Production of heterodimeric proteins	Patent 11492371 was granted and assigned to Genmab A/S on November, 2022 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11492371	November 8, 2022
‌ US Patent 11548952 Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma	Patent 11548952 was granted and assigned to Genmab A/S on January, 2023 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11548952	January 10, 2023
‌ US Patent 7329405 Human antibodies specific for interleukin 15 (IL-15)	Patent 7329405 was granted and assigned to Genmab A/S on February, 2008 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7329405	February 12, 2008
‌ US Patent 7585961 Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)	Patent 7585961 was granted and assigned to Genmab A/S on September, 2009 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7585961	September 8, 2009
‌ US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma	Patent 11535679 was granted and assigned to Genmab A/S on December, 2022 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11535679	December 27, 2022
‌ US Patent 11008399 Antibodies	Patent 11008399 was granted and assigned to Genmab A/S on May, 2021 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11008399	May 18, 2021
‌ US Patent 7622559 Human monoclonal antibodies against interleukin 8 (IL-8)	Patent 7622559 was granted and assigned to Genmab A/S on November, 2009 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7622559	November 24, 2009
‌ US Patent 11359015 Humanized or chimeric CD3 antibodies	Patent 11359015 was granted and assigned to Genmab A/S on June, 2022 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11359015	June 14, 2022
‌ US Patent 10407501 Humanized or chimeric CD3 antibodies	Patent 10407501 was granted and assigned to Genmab A/S on September, 2019 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	10407501	September 10, 2019
‌ US Patent 9862769 Monoclonal antibodies against HER2	Patent 9862769 was granted and assigned to Genmab A/S on January, 2018 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	9862769	January 9, 2018
‌ US Patent 7850962 Human monoclonal antibodies against CD20	Patent 7850962 was granted and assigned to Genmab A/S on December, 2010 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	7850962	December 14, 2010
‌ US Patent 11608383 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma	Patent 11608383 was granted and assigned to Genmab A/S on March, 2023 by the United States Patent and Trademark Office.	‌ Genmab A/S	‌ Genmab A/S	United States Patent and Trademark Office	11608383	March 21, 2023
‌ US Patent 9150663 Heterodimeric antibody Fc-containing proteins and methods for production thereof	Patent 9150663 was granted and assigned to Genmab A/S on October, 2015 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	9150663	October 6, 2015
‌ US Patent 9540433 Human antibodies and antibody-drug conjugates against CD74	Patent 9540433 was granted and assigned to Genmab A/S on January, 2017 by the United States Patent and Trademark Office.		‌ Genmab A/S	United States Patent and Trademark Office	9540433	January 10, 2017

Results per page:

81 results

0 selected

81 results

0 selected